Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The homeopathic preparation vertigoheel (R) versus Ginkgo biloba in the treatment of vertigo in an elderly population: A double-blinded, randomized, controlled clinical trial

Lookup NU author(s): Wolfgang Issing

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Objective: Alternative medical practices are common in the treatment of vertigo. This study compared the effects of Ginkgo biloba treatment with the homeopathic remedy Vertigoheel((R)) (Biologische Heilmittel Heel GmbH, Baden-Baden, Germany). Design: Randomized, double-blinded, parallel group study. Subjects: One hundred and seventy (170) patients, ages 60-80 years, with atherosclerosis-related vertigo. Interventions: Patients were randomly allocated to receive treatment with either Vertigoheel (n = 87) or G. biloba (n = 83). Outcome measures: The results were analyzed for the non-inferiority of Vertigoheel to G. biloba on the combined endpoint of changes from baseline to week 6 in dizziness score (assessed by questionnaire), frequency, duration, and intensity of vertigo episodes (recorded in patient diaries). Results: Both treatments improved vertigo status. From a baseline mean value of 26.1 +/- 5.2 (on a 50-point scale) in the Vertigoheel group, the dizziness questionnaire score improved by - 10.6 +/- 10.0, and by - 10.7 +/- 9.0 from 25.8 +/- 4.7 in the G. biloba group. Statistical analysis of this endpoint showed that Vertigoheel was not inferior to G. biloba. The 95% confidence interval for the difference between treatment did not reach the inferiority threshold of 0.36 at any of the time points tested. The results were supported by the results of a line walking, test, Unterberger's stepping test, and patient and physician global assessments of therapeutic effect. Both treatments were well tolerated. Conclusions: Vertigoheel is an appealing alternative to established G. biloba therapy for atherosclerosis-related vertigo.


Publication metadata

Author(s): Issing W, Klein P, Weiser M

Publication type: Article

Publication status: Published

Journal: Journal of Alternative & Complementary Medicine

Year: 2005

Volume: 11

Issue: 1

Pages: 155-160

ISSN (print): 1075-5535

ISSN (electronic): 1557-7708

Publisher: Mary Ann Liebert, Inc. Publishers

URL: http://dx.doi.org/10.1089/acm.2005.11.155

DOI: 10.1089/acm.2005.11.155


Altmetrics

Altmetrics provided by Altmetric


Share